About Us

Endocrine complications of anorexia nervosa Journal of Eating Disorders Springer Nature Link

Patients with a BMI less than 16 kg/m2, significant recent weight loss, and preexisting electrolyte deficiencies are at especially high risk for developing refeeding syndrome (66). The sodium retention caused by increased insulin levels can lead to hypervolemia and resultant cardiac and respiratory failure. Slow, careful introduction of nutrients must be initiated with particular attention to maintaining normal electrolyte levels and avoiding drastic fluid shifts. Patients with severe AN generally have hypercholesterolemia with normal free fatty acid levels that are attributed to accelerated cholesterol metabolism (61). Unfortunately, https://sibze.ru/index.php?subaction=userinfo&user=napkindanger7 deficits in bone accrual in adolescence may result in permanently decreased bone density despite weight recovery (59). It has positive effects on bone health (stimulation of bone metabolism and activation of vitamin D to 1,25-dihydroxycholecalciferol) in patients with GH deficiency (57).
For example, weight restoration results in resumption of menstrual cycles in most, but not all, women with AN. An important component in the treatment of AN is the evaluation and management of its endocrine complications, including functional hypogonadotropic hypogonadism and increased fracture risk. Studies have shown that rhIGF-1, which addresses the relative IGF-1 deficiency in the disorder, followed by risedronate increases BMD at the lateral spine, but not at other skeletal sites, in women with AN and low BMD compared to placebo . Risedronate, a bisphosphonate that suppresses bone resorption, increases spine BMD by 3.2% and hip BMD by 1.9% over 12 months in women with AN . This is because bone metabolism may be compromised even after just 6–12 months of amenorrhea. It is important to note that the doses of transdermal estradiol used in these studies do not provide contraceptive benefit and that patients must be informed about this. In women with AN, an open-label weekly transdermal estradiol (0.045 mg/day) and levonorgestrel (0.015 mg/day) patch increased spine BMD over 6 months .
The adipokine, leptin, is low in anorexia nervosa due to reduced fat mass, whereas adiponectin levels have been variably reported to be unchanged, increased or reduced. Anorexia nervosa commonly results in hypothalamic amenorrhea, with reduced gonadotropin-releasing hormone (GnRH) and luteinizing hormone (LH) pulsatility and resultant low estradiol and testosterone levels. However, no investigators have specifically examined the role of kisspeptin in women with anorexia nervosa, including whether underlying genetic variability in kisspeptin signalling might contribute to individual predisposition to hypothalamic amenorrhea24.
In contrast, in adolescent girls with AN, both bone formation and bone resorption are lower compared to controls , indicative of reduced bone turnover and often resulting in failure to reach peak bone mass. In contrast to other adipose depots, bone marrow adipose tissue, assessed non-invasively by proton magnetic resonance spectroscopy (1H-MRS), paradoxically increases in the early stages of starvation and is higher in women with AN compared to controls . Serum levels of myostatin, a myokine that acts as an inhibitor of muscle growth, are lower in women with AN compared to controls . Studies have shown that adolescent boys with AN have relatively less loss of fat mass in the trunk than the extremities , and that with weight regain, both adolescent boys and women regain relatively more fat in the trunk than the extremities 32, 82.
Our group has previously reported strong associations between change in free testosterone and change in surrogate markers of bone formation in adolescent girls with anorexia nervosa (50). Moreover, we have recently shown that low-dose buy testosterone cream replacement therapy increases bone density at the hip and radius in women with severe androgen deficiency due to hypopituitarism (43). Bone density is reduced in men with hypogonadism, and testosterone replacement results in reversal of the bone loss incurred. In contrast, the data regarding the effects of oral contraceptives on androgen levels in healthy women of reproductive age are congruent in that they clearly demonstrate decreases in free testosterone and DHEAS in healthy women of reproductive age (27–35). Linear regression models were constructed for total testosterone, free testosterone, and DHEAS on bone density and body composition variables; the results are shown in Table 3. We also investigated whether androgen and preandrogen levels were predictors of body composition and bone density.
Biochemical parameters such as bone turnover markers, total and free testosterone, prolactin, LH, FSH, ACTH, IGF-1, GH, and total and free T3 levels were not universally assessed in all 4 patients during their admission and would have possibly provided an opportunity for further analysis and conclusions. Low levels of testosterone buy online and dehydroepiandrosterone may contribute to low bone mass during puberty. A decrease in normal body weight by 10 to 15% can cause amenorrhea (17).
While it may seem sensible from an evolutionary point of view to pause the reproductive system during chronic starvation, the negative effects on BMD and reproductive functions have instigated numerous studies on, mostly, oral hormone replacement. Subsequently, lower LH pulsatility, as well as reduced levels of oestradiol and testosterone, can be observed in females. Due to these adverse effects of hypercortisolaemia, pharmacological interventions could be considered at first sight, but are not recommended due to, again, the adaptive nature of this endocrine response in order to preserve euglycaemia and normotension . The equivalent clinical syndrome of hypercortisolaemia in non-anorexic patients would be Cushing syndrome; albeit being clearly distinct in appearance, it may still be of interest to compare their clinical parallels. In AN, high levels of ACTH and cortisol can be observed, indicating a chronically stimulated state of the HPA axis 7,8. While these symptoms in a hypothyroid patient would prompt doctors to substitute thyroid hormones in order to avoid these disturbances, in patients with AN, it is important to regard the sequence of cause and effect of low-T3 Syndrome.
Consistent with these data, measures of dietary restraint are positively correlated with plasma PYY3-36 levels in women with AN . Further studies are needed to better understand the role of exogenous ghrelin and ghrelin agonists in patients with AN. Exogenous IV ghrelin infused twice a day preprandially for two weeks improved gastrointestinal symptoms including epigastric discomfort and constipation and increased reported feelings of hunger in four out of five patients with AN . A couple studies have suggested a potential role of pharmacologic interventions of ghrelin in patients with AN. Patients with AN have lower levels of oxytocin both in the cerebrospinal fluid and the serum . In patients with SIADH, ingestion of water does not adequately suppress ADH, which leads to water retention, increases total body water, and lower the plasma sodium concentration by dilution.
It is unclear whether the acute ghrelin response to food intake is normal or impaired in women with AN, and this may depend on caloric content or macronutrient composition of meals (83,88,89). Observational studies show a threshold leptin level of 1.85 ng/mL may be necessary for sufficient increases in follicle-stimulating hormone and luteinizing hormone and for the complete recovery of the reproductive system (81). The rise in leptin with increased caloric intake correlates with increasing gonadotropin levels, indicating that increasing leptin may be responsible for activation of the hypothalamic-pituitary-gonadal axis. However, these changes do not correspond to increasing body weight and BMI, suggesting further dysregulation of appetite and weight control mechanisms in AN.